Question 1

A patient is taking desmopressin (DDAVP)nasal spray.What important information should the nurse tell the patient about this nasal spray?

Accepted Answer

A) The spray should not be inhaled. 
B) Inhale deeply after each spray is administered. 
C) The spray should be taken only if symptoms are present. 
D) Nasal passages should be cleared after the spray is administered. 
A) The spray should not be inhaled. 
B) Inhale deeply after each spray is administered. 
C) The spray should be taken only if symptoms are present. 
D) Nasal passages should be cleared after the spray is administered. A

Question 2

A patient is receiving vasopressin (Pressyn).Which therapeutic response should the nurse expect to see?

Accepted Answer

A) Improved appetite 
B) Increased serum albumin levels 
C) Increased serum potassium levels 
D) Decreased urinary output 
A) Improved appetite 
B) Increased serum albumin levels 
C) Increased serum potassium levels 
D) Decreased urinary output D

Question 3

Which hormone is secreted by the posterior pituitary gland?

Accepted Answer

A) Growth hormone 
B) Follicle-stimulating hormone 
C) Antidiuretic hormone 
D) Prolactin 
A) Growth hormone 
B) Follicle-stimulating hormone 
C) Antidiuretic hormone 
D) Prolactin C

Question 4

An 8-year-old girl has been diagnosed with true pituitary dwarfism.She is being treated with somatropin (Humatrope).
Which change is an expected outcome of using somatropin?

Accepted Answer

A) An increase in growth 
B) Decreased urinary output 
C) Increased muscle strength 
D) An increase in height when she reaches puberty 
A) An increase in growth 
B) Decreased urinary output 
C) Increased muscle strength 
D) An increase in height when she reaches puberty

Question 5

Which drug is contraindicated with desmopressin (DDAVP)?

Accepted Answer

A) acetylsalicylic acid (Aspirin) 
B) digoxin (Lanoxin) 
C) lithium 
D) penicillin 
A) acetylsalicylic acid (Aspirin) 
B) digoxin (Lanoxin) 
C) lithium 
D) penicillin

Question 6

A patient is about to receive a dose of octreotide (Sandostatin).
Which contraindications or cautions should the nurse assess for? (Select all that apply.)

Accepted Answer

A) Carcinoid crisis 
B) Diarrhea 
C) Diabetes with insulin orders 
D) Chronic renal failure 
E) Orders for oral hypoglycemic drugs
F)Flushing 
A) Carcinoid crisis 
B) Diarrhea 
C) Diabetes with insulin orders 
D) Chronic renal failure 
E) Orders for oral hypoglycemic drugs
F)Flushing

Question 7

What is cosyntropin (Cortrosyn)used to diagnosis?

Accepted Answer

A) Adrenocortical insufficiency 
B) Myasthenia gravis 
C) Diabetes insipidus 
D) Scleroderma 
A) Adrenocortical insufficiency 
B) Myasthenia gravis 
C) Diabetes insipidus 
D) Scleroderma

Question 8

Which are common adverse effects of desmopressin (DDAVP)?

Accepted Answer

A) Uterine cramping and constipation 
B) Increased blood pressure and nausea 
C) Headache and chills 
D) Sweating and low blood pressure 
A) Uterine cramping and constipation 
B) Increased blood pressure and nausea 
C) Headache and chills 
D) Sweating and low blood pressure

Question 9

A patient is taking desmopressin.What important information should the nurse give the patient about this drug therapy?

Accepted Answer

A) It cannot be taken while the patient is taking a glucocorticoid. 
B) It has an enhanced effect if taken with lithium carbonate. 
C) It has a reduced effect if taken with carbamazepine. 
D) The patient should avoid consuming alcohol during therapy. 
A) It cannot be taken while the patient is taking a glucocorticoid. 
B) It has an enhanced effect if taken with lithium carbonate. 
C) It has a reduced effect if taken with carbamazepine. 
D) The patient should avoid consuming alcohol during therapy.

Question 10

The nurse is teaching a patient how to administer desmopressin 10 mcg intranasal.The nurse instructs the patient to press the spray pump how many times to deliver a 10-mcg dose?

Accepted Answer

A) Once 
B) Twice 
C) Five times 
D) Ten times 
A) Once 
B) Twice 
C) Five times 
D) Ten times

Question 11

A 16-year-old boy who is taking somatropin (Humatrope)has a growth on the back of his hand.When the nurse asks him about it,he says that he has had it several weeks,but it has recently started to get bigger.What should be the next intervention?

Accepted Answer

A) The growth should be tested. 
B) The somatropin dosage should be increased. 
C) The somatropin should be stopped immediately. 
D) The growth should be documented and monitored for changes. 
A) The growth should be tested. 
B) The somatropin dosage should be increased. 
C) The somatropin should be stopped immediately. 
D) The growth should be documented and monitored for changes.

Exam 31: Pituitary Drugs

A patient is taking desmopressin (DDAVP)nasal spray.What important information should the nurse tell the patient about this nasal spray?

A patient is receiving vasopressin (Pressyn).Which therapeutic response should the nurse expect to see?

Which hormone is secreted by the posterior pituitary gland?

An 8-year-old girl has been diagnosed with true pituitary dwarfism.She is being treated with somatropin (Humatrope). Which change is an expected outcome of using somatropin?

Which drug is contraindicated with desmopressin (DDAVP)?

A patient is about to receive a dose of octreotide (Sandostatin). Which contraindications or cautions should the nurse assess for? (Select all that apply.)

What is cosyntropin (Cortrosyn)used to diagnosis?

Which are common adverse effects of desmopressin (DDAVP)?

A patient is taking desmopressin.What important information should the nurse give the patient about this drug therapy?

The nurse is teaching a patient how to administer desmopressin 10 mcg intranasal.The nurse instructs the patient to press the spray pump how many times to deliver a 10-mcg dose?

A 16-year-old boy who is taking somatropin (Humatrope)has a growth on the back of his hand.When the nurse asks him about it,he says that he has had it several weeks,but it has recently started to get bigger.What should be the next intervention?

Nursing Practice in Canada and Drug Therapy

Pharmacological Principles

Legal and Ethical Considerations

Patient Focused Considerations

Gene Therapy and Pharmacogenomics

Medication Errors: Preventing and Responding

Patient Education and Drug Therapy

Over-the-Counter Drugs and Natural Health Products

Vitamins and Minerals

Principles of Drug Administration

Analgesic Drugs

General and Local Anaesthetics

Central Nervous System Depressants and Muscle Relaxants

Central Nervous System Stimulants and Related Drugs

Antiepileptic Drugs

Antiparkinsonian Drugs

Psychotherapeutic Drugs

Substance Misuse

Adrenergic Drugs

Adrenergic-Blocking Drugs

Cholinergic Drugs

Cholinergic-Blocking Drugs

Antihypertensive Drugs

Antianginal Drugs

Heart Failure Drugs

Antidysrhythmic Drugs

Coagulation Modifier Drugs

Antilipemic Drugs

Diuretic Drugs

Fluids and Electrolytes

Thyroid and Antithyroid Drugs

Antidiabetic Drugs

Adrenal Drugs

Women’s Health Drugs

Men’s Health Drugs

Antihistamines,Decongestants,Antitussives,and Expectorants

Respiratory Drugs

Acid-Controlling Drugs

Antidiarrheal Drugs and Laxatives

Antiemetic and Anti-nausea Drugs

Nutritional Supplements

Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines

Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs

Antiviral Drugs

Antitubercular Drugs

Antifungal Drugs

Antimalarial, Antiprotozoal, and Anthelmintic Drugs

Anti-Inflammatory and Antigout Drugs

Immunosuppressant Drugs

Immunizing Drugs and Pandemic Preparedness

Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs

Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs

Biological Response–Modifying Drugs

Anemia Drugs

Dermatological Drugs

Ophthalmic Drugs

Otic Drugs

Filters